← All stocks

Pfizer

PFE Net selling
CIK 0000078003 #363 in the set updated 17 Sep 2026
Bought (120 mo)
$4.34M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$159.58M
$0.00 on a plan · $8.92M straight out of an exercise
Sold at will
$150.67M
411 of 430 sales
Net
−$155.25M
−$146.33M against sales at will

By person

33 insiders · 627 transactions
6.2×

A. Bourla holds 6.2 times base salary in stock. $11.30M of shares against $1.80M in salary for 2025.

Salary from the company's own proxy. The shares are what A. Bourla last reported holding, valued at $26.34, the price Common Stock was last bought or sold at on the open market here, on 12 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
READ IAN C
Executive Chairman
$58.03M (91)
−$58.03M
1,639,280
0.0288%
$43.18M
+25.6%
Dolsten Mikael
President R&D
$24.80M (49)
−$24.80M
321,729
0.0056%
$8.47M
+118.0%
DAMELIO FRANK A
Executive Vice President
$15.98M (22)
−$15.98M
555,941
0.0098%
$14.64M
+46.5%
SUSMAN SALLY
Executive Vice President
$11.46M (99)
−$11.46M
168,909
0.0030%
$4.45M
+46.5%
LANKLER DOUGLAS M
Executive Vice President
$10.88M (39)
−$10.88M
163,177
0.0029%
$4.30M
+85.0%
YOUNG JOHN D
Group President
$7.51M (11)
−$7.51M
312,704
0.0055%
$8.24M
+129.9%
MACKENZIE ALEXANDER R
Executive Vice President
$6.99M (38)
−$6.99M
87,280
0.0015%
$2.30M
−37.3%
BOURLA ALBERT
Chairman & CEO
$1.00M (1)
$6.11M (5)
−$5.11M
429,173
0.0075%
$11.30M
+854.7%
HILL CHARLES H
Executive Vice President
$3.73M (10)
−$3.73M
57,328
0.0010%
$1.51M
−8.2%
JOHNSON RADY A
Executive Vice President
$3.33M (25)
−$3.33M
101,974
0.0018%
$2.69M
+98.6%
BLAYLOCK RONALD E
Director
$2.00M (8)
+$2.00M
71,688
0.0013%
$1.89M
Carapezzi William R JR
Executive Vice President
$1.65M (1)
−$1.65M
38,146
0.0007%
$1.00M
−19.1%
DAMICO JENNIFER B.
SVP & Controller
$1.63M (13)
−$1.63M
28,611
0.0005%
$753.61K
+83.7%
OLSON LAURIE J
Executive Vice President
$1.38M (4)
−$1.38M
72,672
0.0013%
$1.91M
+1.0%
Hwang Angela
President, Global Biopharma
$1.30M (4)
−$1.30M
56,475
0.0010%
$1.49M
+253.3%
LUND-JURGENSEN KIRSTEN
Executive Vice President
$1.19M (3)
−$1.19M
4,643
<0.0001%
$122.30K
−67.2%
ROGERS DAWN
Executive Vice President
$1.14M (3)
−$1.14M
4,823
<0.0001%
$127.04K
−64.7%
CANGIALOSI LORETTA V
Sr. Vice President, Controller
$1.08M (2)
−$1.08M
122,075
0.0021%
$3.22M
+78.9%
Buckley Mortimer J
Director
$960.37K (1)
+$960.37K
37,632
0.0007%
$991.23K
GOETTLER MICHAEL
Group President
$762.12K (4)
−$762.12K
36,812
0.0006%
$969.63K
+16.1%
MADDALUNA ANTHONY J
Executive Vice President
$330.00K (1)
−$330.00K
112,087
0.0020%
$2.95M
+25.2%
Gottlieb Scott
Director
$325.80K (6)
+$325.80K
10,000
0.0002%
$263.40K
CORNWELL W DON
Director
$254.80K (4)
−$254.80K
0
0.0000%
$0.00
−100.0%
SAHNI PAYAL
Executive Vice President
$70.17K (1)
−$70.17K
27,667
0.0005%
$728.75K
+91.2%
SMITH JAMES C
Director
$51.43K (1)
$777.12 (1)
+$50.65K
1,542
<0.0001%
$40.62K
Lewis-Hall Freda C
Executive Vice President
375,244
0.0066%
$9.88M
+95.2%
BOSHOFF CHRISTOFFEL
President, R&D
161,379
0.0028%
$4.25M
+39.7%
Pao William
Executive Vice President
97,765
0.0017%
$2.58M
+2,367%
de Germay Alexandre
Executive Vice President
74,377
0.0013%
$1.96M
McDermott Michael
Executive Vice President
74,308
0.0013%
$1.96M
+3.2%
Fonseca Lidia
Executive Vice President
46,455
0.0008%
$1.22M
+238.4%
Denton David M
Chief Financial Officer & EVP
37,919
0.0007%
$998.79K
+662.3%
MALIK AAMIR
Executive Vice President
29,548
0.0005%
$778.29K
+366.7%

Nothing of that kind in this period.

What was left out

Form 4 filings counted 1,477
Amendments (4/A) skipped 5
Filings about a different issuer 13
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 19
Sales at will 411
Transactions with no price 0
Shares from compensation/vesting 30,691,257
Sales filed before the plan box existed 407
History held since 1 Sep 2016